Consumer neurotech evidence standards

The question of what evidence a claim about a brain device should have to meet before it is made to the public, and the gap between that bar and current practice. Direct-to-consumer devices frequently sit in a 'general wellness' category that, in several regulatory regimes, permits claims about focus, relaxation, or performance without the controlled clinical trials a medical claim would require — so a product can market a cognitive benefit on the strength of testimonials, single-arm pilots, or a plausible mechanism rather than a demonstrated effect.

A credible standard borrows from clinical trial methodology: a control condition, and specifically a sham or placebo arm because expectation effects on subjective focus and calm are large; blinding of participants and assessors; pre-registration of the primary outcome to prevent moving the goalposts; adequate sample size; and reporting of effect sizes and null results, not just a significant subgroup. The movement toward such standards is what separates neurotech that earns trust from neurotech that borrows the authority of the word 'brain'.